Creaky Joints Nails New Patient Pregnancy and Family Planning Guidelines
Patients and physicians are riddled with misconceptions when pregnancy is concerned.
The RheumNow Week in Review - 17 November 2017
Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com. This week he covers FDA warnings on gout drugs, steroid use in Australia, biosimilars lost savings and methotrexate hepatotoxicity in psoriatic arthritis (PsA).
ACR 2017 Highlights: RA, SpA, PsA, OA, Lupus and More
Another year and another great ACR meeting. San Diego proved to be a an amazing host with the perfect combination of a convenient convention center with great lodging at walking distances from the conference, amazing food and superb weather.
Podcast of ACR17 - Day 4
Check out this compilation of our ACR17 Day 4 broadcasts, merged into a single one hour podcast !
The ACR17 RheumNow Week in Review - 10 November 2017
This special edition of the RheumNow Week in Review covers highlights of selected sessions from the 2017 ACR annual meeting in San Diego. Dr.
Practice Patterns of PJP Prophylaxis Among ID Physicians
While the incidence of pneumocystis pneumonia (PJP) is low is patients with rheumatologic diseases the mortality is quite high compared to PJP in patients with HIV and infection can be prevented with appropriate prophylaxis.
SLE Clinical Trial Design and Outcome Measures
Clinical trials remain a challenge in SLE and a number of outcome measures have been used with varying success.
Two abstracts in this session sought to address novel ways to assess responses in SLE trials.
Gut-derived TNF: Connection Between Crohn’s and SpA and Sacroiliitis
The pathogenesis between microscopic gut inflammation leading to the development of Crohn’s disease and sacroiliitis has been poorly understood. Dr. Debusschere, et al sought to understand this important link between IBD and axial SpA.
Co-morbid Fibromyalgia
Rheumatoid Arthritis and SLE can be quite challenging to manage in clinical practice, but our arsenal of medications to tone down inflammation is becoming quite broad.
The RheumNow Week in Review - 6 October 2017
The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. In this week's report, Dr.
Social
FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. Naloxone can be administered(+/- medical training) to help reduce opioid overdose deaths https://t.co/9B0hPhOm57
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years 4 months ago
FDA has issued draft guidance on Cannibis research: “Cannabis & Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Draft Guidance for Industry,” outlines FDA’s current thinking on clinical research related cannabis-derived compounds https://t.co/ppvisN1oxU
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years 4 months ago
RheumNow Podcast is Up! Listen to Fauci! Watch it here>> https://t.co/dHq3fP85Ip or Listen to the Podcast>> https://t.co/LdHO7fKUCp
Dr. John Cush @RheumNow ( View Tweet )
5 years 4 months ago
The preliminary #ACR20 schedule is here! Along with all your favorite plenary and networking sessions, the program will feature #Rheumatologist Dr. Anthony Fauci giving us a live update on #COVID19. @ACRheum #ACRConvergence - Where Rheumatology Meets
https://t.co/IWbiVw9PSP
Victoria Shanmugam @VickiShanmugam ( View Tweet )
5 years 4 months ago
JAMA Internal Medicine reports that the number of hydroxychloroquine prescriptions increased from 367,346 to 683,999 (86.2%) from February to March 2020, and chloroquine prescriptions increased 158.6%, rising from 2,346 to 6,066 prescriptions. https://t.co/3MKsu5mOpx
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years 4 months ago
Rheumatology Round-Up from #EULAR2020 w/ Drs. Kavanaugh & Cush. Watch it on RheumNow https://t.co/5v9BTuLrPX or listen to the podcast on iTunes https://t.co/FHJv01AAbC or on Android Sound Cloud https://t.co/nb7iXdRMMb
Dr. John Cush @RheumNow ( View Tweet )
5 years 5 months ago
Increased rate of hospital #COVID-19 cases associated with some but not all chronic #inflammatory or #autoimmune conditions compared with reference population.
The risks seem to depend on age, the specific disease and previous therapies.
https://t.co/8j6R0oO99y https://t.co/n3cEXFx9Kk
Links:
ARD & RMD Open @ARD_BMJ ( View Tweet )
5 years 5 months ago
Global prevalence of juvenile idiopathic arthritis is ~ 2,069,246 < 16 year olds compared with a prevalence of ~ 206,931 < 16 year olds with juvenile SLE. JIA is 10 times more prevalent than lupus in children < 16yrs. https://t.co/2xvhg59c1J
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years 5 months ago
Retrospective study of 2369 patients with Kawasaki disease examined different doses of aspirin showing lower ASA doses of 20–29 mg/kg/day was as effective as 30–50 mg/kg/day in preventing coronary artery aneurysms with no change in IVIG resistance https://t.co/kJgkSSpjyw
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years 5 months ago
#EULAR2020 Round-Up w/ Drs. Kavanaugh & Cush. Watch it on RheumNow https://t.co/5v9BTuLrPX or listen to the podcast on iTunes https://t.co/FHJv01AAbC or on Android Sound Cloud https://t.co/nb7iXdRMMb
Dr. John Cush @RheumNow ( View Tweet )
5 years 5 months ago
